These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11401022)

  • 1. N-methylsuccinimide in plasma and urine as a biomarker of exposure to N-methyl-2-pyrrolidone.
    Jönsson BA; Akesson B
    Int Arch Occup Environ Health; 2001 May; 74(4):289-94. PubMed ID: 11401022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human experimental exposure to N-methyl-2-pyrrolidone (NMP): toxicokinetics of NMP, 5-hydroxy- N-methyl-2-pyrrolidone, N-methylsuccinimide and 2-hydroxy- N-methylsuccinimide (2-HMSI), and biological monitoring using 2-HMSI as a biomarker.
    Jönsson BA; Akesson B
    Int Arch Occup Environ Health; 2003 May; 76(4):267-74. PubMed ID: 12684812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of N-methylsuccinimide and 2-hydroxy-N-methylsuccinimide in human urine and plasma.
    Jönsson BA; Akesson B
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):151-8. PubMed ID: 9518144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human volunteer study on the influence of exposure duration and dilution of dermally applied N-methyl-2-pyrrolidone (NMP) on the urinary elimination of NMP metabolites.
    Keener SA; Wrbitzky R; Bader M
    Int Arch Occup Environ Health; 2007 Feb; 80(4):327-34. PubMed ID: 16897094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human experimental exposure study on the uptake and urinary elimination of N-methyl-2-pyrrolidone (NMP) during simulated workplace conditions.
    Bader M; Wrbitzky R; Blaszkewicz M; van Thriel C
    Arch Toxicol; 2007 May; 81(5):335-46. PubMed ID: 17103143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological monitoring of N-methyl-2-pyrrolidone using 5-hydroxy-N-methyl-2-pyrrolidone in plasma and urine as the biomarker.
    Akesson B; Jönsson BA
    Scand J Work Environ Health; 2000 Jun; 26(3):213-8. PubMed ID: 10901113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of 5-hydroxy-N-methyl-2-pyrrolidone and 2-hydroxy-N-methylsuccinimide in human plasma and urine using liquid chromatography-electrospray tandem mass spectrometry.
    Carnerup MA; Akesson B; Jönsson BA
    J Chromatogr B Biomed Sci Appl; 2001 Sep; 761(1):107-13. PubMed ID: 11585124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological monitoring and health effects of low-level exposure to N-methyl-2-pyrrolidone: a cross-sectional study.
    Haufroid V; Jaeger VK; Jeggli S; Eisenegger R; Bernard A; Friedli D; Lison D; Hotz P
    Int Arch Occup Environ Health; 2014 Aug; 87(6):663-74. PubMed ID: 24078144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major metabolic pathway for N-methyl-2-pyrrolidone in humans.
    Akesson B; Jönsson BA
    Drug Metab Dispos; 1997 Feb; 25(2):267-9. PubMed ID: 9029058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of 5-hydroxy-N-methylpyrrolidone and 2-hydroxy-N-methylsuccinimide in human urine.
    Jönsson BA; Akesson B
    J Chromatogr B Biomed Sci Appl; 1997 Jul; 694(2):351-7. PubMed ID: 9252049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of exposure biomarkers from percutaneous absorption of N-methyl-2-pyrrolidone.
    Akesson B; Carnerup MA; Jönsson BA
    Scand J Work Environ Health; 2004 Aug; 30(4):306-12. PubMed ID: 15458014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental exposure of male volunteers to N-methyl-2-pyrrolidone (NMP): acute effects and pharmacokinetics of NMP in plasma and urine.
    Akesson B; Paulsson K
    Occup Environ Med; 1997 Apr; 54(4):236-40. PubMed ID: 9166128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrations of N-methyl-2-pyrrolidone (NMP) and its metabolites in plasma and urine following oral administration of NMP to rats.
    Carnerup MA; Saillenfait AM; Jönsson BA
    Food Chem Toxicol; 2005 Sep; 43(9):1441-7. PubMed ID: 15951091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambient monitoring and biomonitoring of workers exposed to N-methyl-2-pyrrolidone in an industrial facility.
    Bader M; Rosenberger W; Rebe T; Keener SA; Brock TH; Hemmerling HJ; Wrbitzky R
    Int Arch Occup Environ Health; 2006 May; 79(5):357-64. PubMed ID: 16362322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of N-methyl-2-pyrrolidone (NMP) and its metabolites in plasma and urine from volunteers after experimental exposure to NMP in dry and humid air.
    Carnerup MA; Spanne M; Jönsson BA
    Toxicol Lett; 2006 Apr; 162(2-3):139-45. PubMed ID: 16321482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPE-GC/FTD determination of N-methyl-2-pyrrolidone and its metabolites in urine.
    Kubota R; Endo Y; Takeuchi A; Inoue Y; Ogata H; Ogawa M; Nakagawa T; Onda N; Endo G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):204-10. PubMed ID: 17485256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolites of the alkyl pyrrolidone solvents NMP and NEP in 24-h urine samples of the German Environmental Specimen Bank from 1991 to 2014.
    Ulrich N; Bury D; Koch HM; Rüther M; Weber T; Käfferlein HU; Weiss T; Brüning T; Kolossa-Gehring M
    Int Arch Occup Environ Health; 2018 Nov; 91(8):1073-1082. PubMed ID: 30167791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct determination of N-methyl-2-pyrrolidone metabolites in urine by HPLC-electrospray ionization-MS/MS using deuterium-labeled compounds as internal standard.
    Suzuki Y; Endo Y; Ogawa M; Yamamoto S; Takeuchi A; Nakagawa T; Onda N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3743-7. PubMed ID: 19744900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermal absorption and urinary elimination of N-methyl-2-pyrrolidone.
    Bader M; Keener SA; Wrbitzky R
    Int Arch Occup Environ Health; 2005 Sep; 78(8):673-6. PubMed ID: 16001206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermal exposure to aqueous solutions of N-methyl pyrrolidone.
    Akrill P; Cocker J; Dixon S
    Toxicol Lett; 2002 Aug; 134(1-3):265-9. PubMed ID: 12191887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.